Home › Arrhythmogenic Right Ventricular Dysplasia › Massachusetts
Arrhythmogenic Right Ventricular Dysplasia clinical trials in Massachusetts
3 studies for Arrhythmogenic Right Ventricular Dysplasia are looking for participants at sites in Massachusetts.
Cities in Massachusetts
PKP2-ACM Natural History Study
- Boston Children's Hospital, Boston
RecruitingObservational study
Ages 12 and older · All sexes · Updated Feb 27, 2026 · NCT06644742Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated ARVC
- Brigham and Women's Hospital, Boston
RecruitingPhase 1
Ages 18 to 65 · All sexes · Updated Feb 6, 2025 · NCT06228924Non-interventional Study of Seroprevalence of Pre-existing Antibodies Against Adenovirus-associated Virus Vector (AAV9) and the Progression of Disease in Patients With Plakophilin 2 (PKP2)-Associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
- Brigham and Women's Hospital, Boston
RecruitingObservational study
Ages 14 to 65 · All sexes · Updated Nov 1, 2024 · NCT06311708From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.